Top compounds associated with response to TTLL6


Feature Type Standardized
Nominal ANOVA
mRNA cimetidine CTRPv2 pan-cancer AAC 0.19 0.01
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.078 0.01
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.083 0.01
mRNA TPCA-1 CTRPv2 pan-cancer AAC 0.081 0.01
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.081 0.01
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.083 0.01
mRNA Curcumin CTRPv2 pan-cancer AAC 0.084 0.01
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.072 0.02
mRNA BRD-K86535717 CTRPv2 pan-cancer AAC 0.2 0.02
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.084 0.02
Download CSV